Alzheimer’s can often be a long, drawn-out illness, and for Patti Davis, this long goodbye was also a blessing. Looking back on her late…
In our LiveTalk series, Being Patient spoke with retired physician Jennifer Bute about the early symptoms of Alzheimer’s that she began experiencing in the 2000s,…
Growing evidence shows that dysfunction of the vascular system, vessels that carry blood and fluid throughout the body, is closely linked with cognitive decline…
An emerging brain technology — transcranial magnetic stimulation — offers a non-invasive way to change the brain for the better, using magnets. Proponents believe…
In our LiveTalk series, Being Patient spoke with Marc Archambault about his early symptoms of Alzheimer’s, the ways in which he has adapted his career…
Jacquelyn Revere sheds light on the challenges faced by young dementia caregivers through her incredibly popular TikTok account @MomOfMyMom. This article is part of…
Scientists are looking toward microglia cells as therapeutic targets for Alzheimer’s. Microglia, known as the janitors of our brains, are responsible for clearing harmful…
Researchers share insights on the infectious theory of Alzheimer’s—the idea viruses and bacteria may cause Alzheimer’s. Clinical trials are underway to test this theory….
Nikki Schultek, founder of the global medical research consortium Intracell Research Group, takes a close look at how the COVID-19 pandemic may prompt a…
Alzheimer’s is a complex disease, and studies that follow participants over extended periods of time can gather troves of data on the progression of…
University of Montreal neuropsychology PhD student Émilie Delage, University of Quebec at Montreal professor of psychology and neuropsychology Isabelle Rouleau and University of Montreal…
IMAGE: Photobiomodulation tabletop device Beacon40 by neurotechnology company Bright Could flickering lights have brain health benefits? Research around experimental therapies involving external stimuli —…
The human body is host to trillions of microscopic organisms — collectively called the microbiome — that shape our health across the lifespan. This…
A recent cell study shows that experimental Parkinson’s and Alzheimer’s antibodies may trigger harmful brain inflammation—which could explain clinical trials’ dismal failure rates. In…
A recent analysis reveals that people with Alzheimer’s taking Alzheimer’s drug galantamine (Razadyne), approved nearly two decades ago, show moderate cognitive benefits as well…